Outcomes of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with the Upfront Single Agent Pembrolizumab: A Retrospective and Multicentric Study of the ESCKEYP GFPC Cohort
This study revealed the feasibility and outcome of front-line pembrolizumab treatment in this population with BM.PMID:38534959 | PMC:PMC10969391 | DOI:10.3390/curroncol31030126
Source: Current Oncology - Category: Cancer & Oncology Authors: Simon Nannini Florian Guisier Hubert Curcio Charles Ricordel Pierre Demontrond Safa Abdallahoui Seyyid Baloglu Laurent Greillier Christos Chouaid Roland Schott Source Type: research
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Lung Cancer | Neurology | Non-Small Cell Lung Cancer | Radiation Therapy | Study